Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01797848 |
|---|---|
| Brief Title: | Efficacy and Safety Evaluation of a Treatment Consisting of Peg Interferon Alfa + Ribavirin + Daclatasvir in HCV Genotype 1 and 4 Treatment naïve Patients (COMMAND-Asia) |
| First Submitted : | February 21, 2013 |
| First Submitted that Met QC Criteria : | February 21, 2013 |
| First Posted : | February 25, 2013 (Estimate) |
| Last Update Submitted that Met QC Criteria : | November 21, 2013 |
| Last Update Posted : | November 25, 2013 (Estimate) |